NPF honors all Dad’s this Father’s Day, and it’s part of the reason we want to help you find the perfect gift. While each person with Parkinson’s has individualized symptoms and a different rate of PD progression, NPF hopes that at least one gift on this list can bring happiness to a person you know with PD.
Blog Introduction Text
Welcome to the National Parkinson Foundation's blog, where you can keep up-to-date on the latest research, read about what's hot in the Parkinson's community, learn caregiving tips and more.
What occupies you? Occupation is defined as the activity that occupies your time. This doesn’t necessarily mean your job; it includes all the activities that make up your day, from getting dressed and preparing meals to gardening or playing cards with friends. The goal of occupational therapy is to help people achieve independence, meaning and satisfaction in all aspects of their lives. Continued participation in meaningful occupations (work, leisure, and self-care) keeps your well-being balanced.
In August 2015, an unlikely, unofficial alliance was formed. One e-mail led the National Parkinson Foundation (NPF), LAN Airlines and the Chilean Consulate General to work together. Through shared determination they ended up making lives better for more than 200 people with Parkinson’s in Chile.
I arrived at my Parkinson’s Caregivers Support Group a little late. Getting out of the house with Gerry, my husband, had taken a bit longer than our new normal. And, of course, when I tried to hurry so that I could be on time, it took even longer.
In January 2012 we reported on the possibility of a blood test for Parkinson’s disease detection. Four years have now passed, and this week a different group from La Trobe University led by Paul Fisher say they have developed and potentially effective blood test for Parkinson’s disease detection. In this month’s What’s Hot in PD? Column, we will update our previous article and comment on this new observation.
April 29, 2016 – Today, the FDA approved Nuplazid (pimavanserin) as the first drug to treat hallucinations and delusions associated with Parkinson’s disease psychosis, which affects up to 40% of people with Parkinson’s.
Every year, NPF hosts the Centers of Excellence Leadership Conference, where leaders from our 41 Centers of Excellence — medical centers located around the world with the world's leading Parkinson's specialists — attend and present their cutting-edge research and expert care findings.
While each person with Parkinson’s has individualized symptoms and a different rate of PD progression, NPF hopes that one gift on this list can bring happiness to a person you know with PD, and make life just a little bit easier for him or her.
April is Parkinson's Awareness Month and we want you to advocate for Parkinson's awareness. We have collected 7 inspiring ways you can get involved in the Parkinson's community this month. And don't worry — we have many other ways you can stay involved year-round!
This week the FDA approved the drug Pimavanserin (Nuplazid) for the treatment of Parkinson’s disease psychosis. There has been a critical, unmet need for development of better drugs to address hallucinations and psychosis in the setting of Parkinson's disease. We have learned over many years that typical high potency neuroleptic antipsychotic drugs (e.g.